Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A
Stock Information for Cocrystal Pharma Inc.
Loading
Please wait while we load your information from QuoteMedia.